MYCOBACTERIUM COMBINED PANEL TB.COM Test
Test Cost: AED 630.0
Symptoms, Diagnosis, and Test Details
The MYCOBACTERIUM COMBINED PANEL TB.COM test is a diagnostic test used to detect and identify different species of Mycobacterium, including Mycobacterium tuberculosis complex (MTBC) and non-tuberculous mycobacteria (NTM). This test combines multiple methods, such as nucleic acid amplification, DNA sequencing, and culture-based techniques, to provide comprehensive and accurate results.
It can be used for the diagnosis of tuberculosis (TB) and other mycobacterial infections. The MYCOBACTERIUM COMBINED PANEL TB.COM test is typically performed on respiratory samples, such as sputum or bronchoalveolar lavage, as well as other clinical specimens, including tissue biopsies and body fluids. It can detect the presence of mycobacteria and determine the species or strain causing the infection.
The test is useful in guiding appropriate treatment decisions, as different mycobacterial species may require different antibiotic regimens. It also helps in monitoring treatment response and detecting drug resistance in MTBC strains.
Overall, the MYCOBACTERIUM COMBINED PANEL TB.COM test is a valuable tool in the diagnosis and management of mycobacterial infections, particularly tuberculosis.
Test Components:
- Mycobacterium Tuberculosis, PCR
- Culture, AFB Rapid
- Ziehl Neelson Stain
Price: 630.0 AED
Sample Condition:
Submit first morning Sputum on 3 consecutive days OR 5-10 mL Body fluids/aspirate OR 2 mL CSF in a sterile screw capped container OR 100 mL first morning Urine collected on 3 consecutive days OR Fresh tissue biopsies including endometrial aspirate/curettage in sterile normal saline OR 1-5 mL whole blood/Bone Marrow in 1 Lavender Top (EDTA)/Yellow Top (ACD) tube OR 1-2 mL Menstrual blood in a sterile screw capped container AND 3 mL (1 mL min.) blood in Myco F/Lytic bottle available from LPL. All specimens to be collected aseptically and shipped refrigerated.
Report Delivery:
Sample Daily by 3.30 pm
Report Interim: 14 days & 4 weeks
Final: 6 weeks
Method:
Real Time PCR, Automated fluorescent, ICT
Test Type:
Tuberculosis
Doctor:
Physician, Chest Physician
Test Department:
Pre Test Information: No special preparation required
| Test Name | MYCOBACTERIUM COMBINED PANEL TB.COM Test |
|---|---|
| Components | *Mycobacterium Tuberculosis, PCR *Culture, AFB Rapid *Ziehl Neelson Stain |
| Price | 630.0 AED |
| Sample Condition | Submit first morning Sputum on 3 consecutive days OR 5\u0192??10 mL Body fluids\/ aspirate OR 2 mL CSF in a sterile screw capped container OR 100 mL first morning Urine collected on 3 consecutivedaysORFreshtissue biopsies including endometrial aspirate \/ curettage in sterile normal saline OR 1-5 mL whole blood\/ Bone Marrow in 1 Lavender Top (EDTA) \/ Yellow Top (ACD) tube OR 1-2 mL Menstrual blood in a sterile screw capped container AND 3 mL (1 mL min.) blood in Myco F \/ Lytic bottle available from LPL. All specimens to be collected aseptically and shipped refrigerated. |
| Report Delivery | Sample Daily by 3.30 pm Report Interim: 14 days & 4 weeks Final: 6 weeks |
| Method | Real Time PCR, Automated fluorescent, ICT |
| Test type | Tuberculosis |
| Doctor | Physician, Chest Physician |
| Test Department: | |
| Pre Test Information | No special preparation required |
| Test Details |
The MYCOBACTERIUM COMBINED PANEL TB.COM test is a diagnostic test used to detect and identify different species of Mycobacterium, including Mycobacterium tuberculosis complex (MTBC) and non-tuberculous mycobacteria (NTM). This test combines multiple methods, such as nucleic acid amplification, DNA sequencing, and culture-based techniques, to provide comprehensive and accurate results. It can be used for the diagnosis of tuberculosis (TB) and other mycobacterial infections. The MYCOBACTERIUM COMBINED PANEL TB.COM test is typically performed on respiratory samples, such as sputum or bronchoalveolar lavage, as well as other clinical specimens, including tissue biopsies and body fluids. It can detect the presence of mycobacteria and determine the species or strain causing the infection. The test is useful in guiding appropriate treatment decisions, as different mycobacterial species may require different antibiotic regimens. It also helps in monitoring treatment response and detecting drug resistance in MTBC strains. Overall, the MYCOBACTERIUM COMBINED PANEL TB.COM test is a valuable tool in the diagnosis and management of mycobacterial infections, particularly tuberculosis. |
